Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,096 | 47,820 | 56,099 | 70,105 | 77,998 |
| Receivables | 1,129 | 2,096 | 2,403 | 1,516 | 2,512 |
| Other current assets | 1,186 | 1,061 | 960 | 919 | 815 |
| TOTAL | $43,411 | $50,977 | $59,462 | $72,540 | $81,325 |
| Non-Current Assets | |||||
| PPE Net | 3,650 | 3,915 | 4,004 | 4,038 | 4,439 |
| Investments And Advances | 3,240 | 3,240 | 3,240 | 3,332 | 3,424 |
| Other Non-Current Assets | 200 | 200 | 200 | 200 | 200 |
| TOTAL | $7,090 | $7,355 | $7,444 | $7,570 | $8,063 |
| Total Assets | $50,501 | $58,332 | $66,906 | $80,110 | $89,388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,486 | 3,983 | 4,099 | 6,331 | 6,881 |
| Other current liabilities | 115 | 115 | 115 | 115 | 115 |
| TOTAL | $6,805 | $4,302 | $4,418 | $6,650 | $7,200 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 204 | 204 | 204 | 204 | 204 |
| Other Non-Current Liabilities | 1,039 | 999 | 963 | 1,497 | 1,595 |
| TOTAL | $1,048 | $1,059 | $1,074 | $1,659 | $1,808 |
| Total Liabilities | $7,853 | $5,361 | $5,492 | $8,309 | $9,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,915 | 33,882 | 33,862 | 33,862 | 33,763 |
| Common Shares | 44 | 44 | 44 | 44 | 44 |
| Retained earnings | -423,781 | -412,480 | -401,760 | -388,674 | -377,928 |
| Other shareholders' equity | -1 | -1 | -1 | -9 | -17 |
| TOTAL | $42,648 | $52,971 | $61,414 | $71,801 | $80,380 |
| Total Liabilities And Equity | $50,501 | $58,332 | $66,906 | $80,110 | $89,388 |